Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide. - CRS. Experts. Early Phase.

Impact of impaired renal function on the pharmacokinetics of the antiepileptic drug lacosamide.

Science

ShareTwitter FacebookXingLinkedin

First published in Clinical Pharmacokinetics on 2013 Oct.
Clin Pharmacokinet. 2013 Oct;52(10):897-906. doi: 10.1007/s40262-013-0080-7.

Authors: Cawello W, Fuhr U, Hering U, Maatouk H, Halabi A.

Read more

Download full article as Pdf file:

REACHING OUT IS EASY AND FAST – LET’S TALK

Prof. Dr. Thomas Forst

Chairman of the Executive Board

LET’S TALK SCIENCE

+49 621 150 45 – 0

Martin Mulder

Senior Vice President Corporate & Business Development

LET’S TALK BUSINESS

+49 621 150 45 – 0

antiepileptic drug hemodialysis pharmacokinetics renal impairment safety

You May Also Like

Science 16. November 2023

Pharmacokinetics, Safety, and Tolerability of the Novel Tetrameric, High-Relaxivity, Macrocyclic Gadolinium-Based Contrast Agent Gadoquatrane in Healthy Adults

Science 16. November 2023

Effect of nivasorexant (ACT-539313), a selective orexin-1-receptor antagonist, on multiple cytochrome P450 probe substrates in vitro and in vivo using a cocktail approach in healthy subjects

Science 25. Mai 2023

CVOT Summit 2022 Report: new cardiovascular, kidney, and glycemic outcomes